NCT06650215

Brief Summary

Walking tests are widely used to assess functional capacity in different populations because of their ease of administration, interpretability and representativeness of activities of daily living.The aim of our study was to investigate the validity and reliability of the 2-minute walk test in hemodialysis patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 21, 2024

Completed
11 days until next milestone

Study Start

First participant enrolled

November 1, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

November 5, 2024

Status Verified

October 1, 2024

Enrollment Period

7 months

First QC Date

October 18, 2024

Last Update Submit

November 3, 2024

Conditions

Keywords

Hemodialysis

Outcome Measures

Primary Outcomes (3)

  • Exercise capacity

    Will be assessed using the 2 minute walk test.

    5 minutes

  • Exercise capacity

    Will be assessed using the 6 minute walk test.

    10 minutes

  • Muscle functions

    Will be evaluated with 1 minute sit-stand test.

    1 minutes

Secondary Outcomes (1)

  • Physical activity

    5 minutes

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hemodialysis patients who are clinically stable, between 18 and 80 years of age, who are being followed up at the Hemodialysis Unit of Kırşehir Education and Research Hospital, who do not have any exclusion criteria, who can adapt to the evaluations to be made, who are willing to volunteer and who sign the informed consent form will be included in the study.

You may qualify if:

  • Patients with end stage renal disease receiving hemodialysis
  • Being clinically stable
  • Being Aged between 18-80
  • Volunteering to participate in this study

You may not qualify if:

  • Having a musculoskeletal problem that may affect functional capacity measurement
  • Having had a cardiac event in the past 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kirsehir Ahi Evran University

Kırşehir, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Kidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Merve Firat

    Kirsehir Ahi Evran University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 18, 2024

First Posted

October 21, 2024

Study Start

November 1, 2024

Primary Completion

June 1, 2025

Study Completion

December 1, 2025

Last Updated

November 5, 2024

Record last verified: 2024-10

Locations